Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHUKRA PHARMA vs LACTOSE INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHUKRA PHARMA LACTOSE INDIA SHUKRA PHARMA/
LACTOSE INDIA
 
P/E (TTM) x 19.3 33.2 58.0% View Chart
P/BV x 14.1 4.3 326.4% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 SHUKRA PHARMA   LACTOSE INDIA
EQUITY SHARE DATA
    SHUKRA PHARMA
Mar-23
LACTOSE INDIA
Mar-23
SHUKRA PHARMA/
LACTOSE INDIA
5-Yr Chart
Click to enlarge
High Rs8996 92.1%   
Low Rs1139 28.3%   
Sales per share (Unadj.) Rs53.752.3 102.7%  
Earnings per share (Unadj.) Rs4.01.0 418.7%  
Cash flow per share (Unadj.) Rs5.74.7 121.7%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs23.132.2 71.6%  
Shares outstanding (eoy) m10.9612.59 87.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.91.3 71.7%   
Avg P/E ratio x12.470.6 17.6%  
P/CF ratio (eoy) x8.814.5 60.5%  
Price / Book Value ratio x2.22.1 102.8%  
Dividend payout %12.40-   
Avg Mkt Cap Rs m547854 64.1%   
No. of employees `000NANA-   
Total wages/salary Rs m44122 36.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m588658 89.4%  
Other income Rs m127 164.2%   
Total revenues Rs m600665 90.2%   
Gross profit Rs m54115 46.8%  
Depreciation Rs m1847 39.2%   
Interest Rs m360 4.7%   
Profit before tax Rs m4415 303.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m03 13.7%   
Profit after tax Rs m4412 364.5%  
Gross profit margin %9.117.4 52.4%  
Effective tax rate %0.817.5 4.5%   
Net profit margin %7.51.8 407.7%  
BALANCE SHEET DATA
Current assets Rs m531375 141.5%   
Current liabilities Rs m425266 160.0%   
Net working cap to sales %18.016.6 108.1%  
Current ratio x1.21.4 88.5%  
Inventory Days Days046 0.0%  
Debtors Days Days1,873693 270.2%  
Net fixed assets Rs m219643 34.1%   
Share capital Rs m39126 31.1%   
"Free" reserves Rs m214280 76.4%   
Net worth Rs m253406 62.4%   
Long term debt Rs m38330 11.4%   
Total assets Rs m7501,018 73.7%  
Interest coverage x16.81.2 1,352.7%   
Debt to equity ratio x0.10.8 18.3%  
Sales to assets ratio x0.80.6 121.4%   
Return on assets %6.37.1 87.8%  
Return on equity %17.43.0 584.5%  
Return on capital %16.210.2 159.4%  
Exports to sales %00-   
Imports to sales %031.3 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA206 0.0%   
Fx inflow Rs m0104 0.0%   
Fx outflow Rs m0209 0.0%   
Net fx Rs m0-105 -0.0%   
CASH FLOW
From Operations Rs m3281 39.3%  
From Investments Rs m-44-10 434.9%  
From Financial Activity Rs m49-84 -59.0%  
Net Cashflow Rs m37-13 -274.5%  

Share Holding

Indian Promoters % 51.0 53.7 95.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.1 0.6 17.7%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 46.3 105.8%  
Shareholders   10,963 16,088 68.1%  
Pledged promoter(s) holding % 0.0 26.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHUKRA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RELISH PHARMA vs LACTOSE INDIA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RELISH PHARMA vs LACTOSE INDIA Share Price Performance

Period RELISH PHARMA LACTOSE INDIA S&P BSE HEALTHCARE
1-Day -2.00% -1.83% 1.18%
1-Month 18.32% -2.41% -0.75%
1-Year 528.10% 226.47% 61.82%
3-Year CAGR 229.50% 73.96% 18.16%
5-Year CAGR 114.18% 33.74% 19.79%

* Compound Annual Growth Rate

Here are more details on the RELISH PHARMA share price and the LACTOSE INDIA share price.

Moving on to shareholding structures...

The promoters of RELISH PHARMA hold a 51.0% stake in the company. In case of LACTOSE INDIA the stake stands at 53.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RELISH PHARMA and the shareholding pattern of LACTOSE INDIA.

Finally, a word on dividends...

In the most recent financial year, RELISH PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 12.4%.

LACTOSE INDIA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of RELISH PHARMA, and the dividend history of LACTOSE INDIA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.